Pharmacopeia



19


Pharmacopeia


Gail D. Anderson


Department of Pharmacy, UW Regional Epilepsy Center, University of Washington, Seattle, WA, USA






Table 19.1. Approved indications of the antiepileptic drugs.



image



image


Table 19.2. Chemistry and pharmacology of the antiepileptic drugs.



















































































































Drug Chemical structure Proposed mechanism of action
Acetazolamide 5-Acetamido-1,3,4-thiadiazole-2-sulfonamide Inhibits carbonic anhydrase
Carbamazepine 5-Carbamoil-5H-dibenz[b,f ]azepine Inhibits voltage-gated sodium channels
Stabilizes neuronal membranes and limits sustained repetitive firing
Clobazam 7-chloro-1-methyl-5-phenyl-1H-1,5-benzodiazepine-2,4(3H,5H)dione Enhances GABAA receptor-mediated chloride currents
Clonazepam 5-(2-Chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4 benzodiazepin-2-one Enhances GABAA receptor-mediated chloride currents
Diazepam 7-Chloro-1,3-dihydro-1-methyl-5-phenyl-1,4 benzodiazepin-2(3H)-one Enhances GABAA receptor-mediated chloride currents
Eslicarbazepine acetate S-(−)-10-acetoxy-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide Voltage-gated sodium channel blocker
Ethosuximide 2-Ethyl-2-methylsuccinimide Attenuates voltage-sensitive calcium channels
Ezogabine N-(2-amino-4-(4-fluorobenzyl-amino)-phenyl) carbamic acid ethyl ester Opens/activates voltage-gated potassium channels (KCNQ2/3, KCNQ3/6)
Potentiates GABA-evoked currents
Felbamate 2-Phenyl-1,3-propanediol dicarbamate Inhibits voltage-gated sodium channels
Inhibits calcium currents through NMDA receptors
Enhances GABAA receptor-mediated chloride channels
Gabapentin 1-Aminomethyl-cyclohexane acetic acid Binds to α2δ subunit of the L-type calcium channel
Increases GABA levels by increasing GABA turnover
Inhibits monoamine neurotransmitter release
Decreases sustained repetitive firing
Lacosamide (R)-2-acetamido-N-benzyl-3-methoxypropionamide Enhances slow inactivation of sodium channels
Lamotrigine 3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine Inhibits sodium currents
Inhibits high-threshold activated calcium channels
Levetiracetam (S)-α-ethyl-2-oxo-1-pyrrolidine acetamide Limits calcium influx through an N-type voltage-sensitive calcium channel
Binds to synaptic vesicle protein 2A
Lorazepam 7-Chloro-5(2-chlorophenyl)-1,3-dihydro-3-dihydroxy-2H-1,4-benzoidazepin-2-one Enhances GABAA receptor-mediated chloride currents
Oxcarbazepine 10,11-Dihydro-10-oxo-carbamazepine Active metabolite, 10-OH-carbazepine, inhibits sustained repetitive firing
Perampanel
Reduces neuronal excitation via the noncompetitive antagonism of the ionotropic AMPA-glutamate receptor on postsynaptic neurons
Phenobarbital 5-Ethyl-5-phenylbarbituric acid Enhances GABAA receptor-mediated chloride currents
Phenytoin 5,5-Diphenylhydantoin Inhibits voltage-gated sodium channels
Stabilizes neuronal membranes and limits sustained repetitive firing
Pregabalin S-(+)-3-aminomethylhexanoic acid; Isobutyl-γ-aminobutyric acid Selective inhibitor of L-type voltage-gated calcium channels containing the α2δ subunit
Primidone 5-Ethyldihydro-5-phenyl-4,6 (1H,5H) pyrimidine-dione Enhances GABAA receptor-mediated chloride currents
Rufinamide 1-(2,6-Difluorophenyl)methyl-1H-1,2,3-triazole-4-carboxamide Sodium channel blocker
Stiripentol 4,4-Dimethyl-1-[(3,4 methylenedioxy) phenyl]-1-penten-3-ol Enhances GABAergic neurotransmission by increasing the release of GABA and the duration of the activation of GABAA receptors
Tiagabine (−)-R-1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]-3-piperidinecarboxylic acid Selective blocker of neuronal and glial GABA transporters resulting in increased brain GABA levels
Topiramate 2,3:4,5-bis-O-(1-methylethylidene)-βD-fructopyranose sulfamate Blocks sustained repetitive firing and inhibits sodium currents
Decreases glutamate-mediated excitation via the AMPA/kainate receptor
Enhances GABAA currents
Potentiates hyperpolarizing potassium currents
Inhibits high-threshold activated calcium channels
Inhibits carbonic anhydrase
Valproate 2-Propylpentanoic acid Attenuates voltage-sensitive calcium channels, inhibits sodium channels, and stabilizes neuronal membranes
Enhances GABAergic-mediated inhibition
Vigabatrin 4-Amino-5-hexenoic acid; γ-vinyl GABA Irreversibly inhibits GABA transaminase, resulting in increased brain GABA levels
Zonisamide 1,2-Benzisoxazole-3-methane sulfonamide Blocks sustained repetitive firing through an effect on voltage-sensitive sodium channels
Reduces T-type calcium currents
Alters ligand binding to GABAA receptor
Inhibits carbonic anhydrase

Table 19.3. Average daily doses of the antiepileptic drugs (monotherapy).



image

Stay updated, free articles. Join our Telegram channel

Tags:
Mar 12, 2017 | Posted by in NEUROLOGY | Comments Off on Pharmacopeia

Full access? Get Clinical Tree

Get Clinical Tree app for offline access